EAP® Abutments

EAP® Abutments are implant abutments featuring a unique titanium shell design where titanium is always in contact with gingiva. The product line is supported by 150+ peer-reviewed scientific studies validating core design principles:

Key Design Features

• Titanium Shell Design: Titanium always in contact with gingiva, ensuring zero monomer release from polymeric materials
• Unique Material Configuration: Uses titanium to create a barrier against resin toxicity while supporting soft tissue integration

Scientific Validation (150+ Peer-Reviewed Studies)

Core Design Principles:

Polymer Toxicity Studies: Confirm monomers (Bis-GMA, UDMA, TEGDMA, HEMA) are cytotoxic. EAP® uses titanium at gingiva with zero monomer release, eliminating a major source of peri-implant inflammation.

Cement Studies: 81% of peri-implantitis cases show cement residue. EAP® positions adhesive interface far from bone, reducing cement-related bone loss from 1.37mm (methacrylate cement) to 0.07mm.

Cell Attachment Studies: Anodized titanium enhances fibroblast attachment. EAP® titanium surface supports soft tissue integration through:

• Improved fibroblast attachment and proliferation
• Enhanced collagen synthesis
• Formation of hemidesmosome-like epithelial structures
• Optimized soft tissue barrier function

One-Abutment-One-Time Concept: 0.19mm less bone loss with definitive abutments. EAP® supports patient-specific geometry from day 1, eliminating repeated disconnection/reconnection trauma.

Research Categories:

1. Manipulation & Aesthetics (41 Studies)

• Emergence profile optimization for soft tissue stability
• AI-assisted abutment planning for optimal aesthetics
• One Customized Abutment One Time concept
• Influence of abutment height on marginal bone loss
• Surface modifications for soft tissue seal reinforcement
• Aesthetic outcomes of customized vs. conventional abutments
• One-Abutment-One-Time concept validation
• Platform switching and marginal bone preservation
• Immediate loading with definitive abutments
• Zirconia vs. titanium long-term stability
• Digital workflows for improved precision
• And 30+ additional studies on manipulation, design, and clinical outcomes

2. Polymer & Resin Toxicity (43 Studies)

The research confirms EAP®'s core advantage - eliminating direct monomer contact with soft tissue:

• Bis-GMA > UDMA > TEGDMA > HEMA toxicity ranking confirmed
• Methacrylate monomers cause cytotoxic reactions through:
  • Oxidative stress and glutathione depletion
  • DNA double-strand breaks
  • Inflammatory responses and apoptosis
  • Epigenetic modifications
• BPA release from dental composites (70% of tested materials show measurable release in 24h)
• Incomplete polymerization leads to residual monomer release
• Cell attachment and proliferation inhibition
• Long-term monomer elution continues over 6+ months
• 3D-printed materials show higher cytotoxicity than conventional alternatives

3. Cell Attachment on Titanium (38 Studies)

Documentation of how EAP®'s titanium design supports superior soft tissue integration:

• TiO₂ nanotubes improve fibroblast attachment and reduce bacterial colonization
• Anodized titanium surfaces show optimized biocompatibility
• Titanium: optimal cell attachment; Zirconia: comparable; PEEK: significantly reduced
• Surface modification through anodization improves:
  • Cell attachment and proliferation
  • Gene expression for osteogenic differentiation
  • Hydrophilicity and nanoporous structure
  • Apatite formation and bone integration
• Moderate surface roughness (Ra 0.5-2 μm) shows optimal fibroblast attachment
• Fibroblast attachment 30% higher on anodized vs. non-anodized surfaces
• Titanium enables true epithelial attachment with hemidesmosome formation
• Long-term soft tissue stability over 15 years documented

4. Cement Residue Problems (16 Studies)

EAP® design eliminates the cement problem through strategic abutment design:

• Excess cement found in 68% of implants with peri-implantitis (often undetected)
• Cement residues cause progressive bone resorption and inflammation
• Methacrylate cement associated with 1.37mm bone loss vs. 0.07mm with zinc oxide-eugenol (20-fold difference)
• Cement-mediated peri-implantitis accounts for 1.9-75% of implant failures
• Digital workflows reduce cement excess by 85%
• Subgingival margins show significantly more excess cement
• Custom abutments with supragingival margins significantly reduce cement problems
• Customized abutments effectively minimize cement risks

5. Allergies & Biocompatibility (12 Studies)

• Titanium allergies are rare (0.6% of patients with suspected metal allergy)
• Resin cement residue triggers local allergic reactions and inflammatory responses
• Cross-reactivity between dental methacrylates (70% of HEMA allergy patients react to BisGMA/TEGDMA)
• HEMA contact allergy: 15% prevalence in dental professionals
• Alternative materials for allergic patients: Titanium, zirconia, and glass-ceramic are safe
• Acrylate allergies associated with peri-implant complications (18% of implant failures)
• BisGMA allergy in 8.6% of dental professionals
• Methacrylates are most common allergens in occupational dentistry

Clinical Applications

Indication: Implant-supported crown and bridge restorations where:

• Soft tissue health is a priority
• Polymer toxicity needs to be eliminated
• Long-term bone preservation is critical
• Aesthetic outcomes require precise emergence profile design
• Digital workflow optimization is desired
• One-Abutment-One-Time protocol is preferred

Key Benefits:

1. Zero monomer release from polymeric materials at soft tissue interface
2. Reduced bone loss through cement positioning (0.19mm less with definitive abutment)
3. Enhanced soft tissue integration through anodized titanium surface
4. Elimination of repeated abutment disconnection trauma
5. Superior long-term stability and predictable aesthetic outcomes
6. Reduced risk of peri-implantitis through cement control and biocompatible design
7. Suitable for allergy-prone patients (titanium is biocompatible, no resins at soft tissue)
8. Support for digital workflows and patient-specific customization